From: Homocysteine and lipid profile in children with Juvenile Idiopathic Arthritis
Patients | Controls | |||
---|---|---|---|---|
Epidemiological Characteristics | n | (%) | n | (%) |
Gender | ||||
Female | 37 | (72.6) | 42 | (80.1) |
Male | 14 | (27.4) | 10 | (19.9) |
Origin | ||||
Caucasian | 38 | (74.5) | 27 | (51.9) |
Non Caucasian | 13 | (25,5) | 25 | (48.1) |
Age at disease onset (years) | ||||
Range | 1–12 | - | ||
Mean ± SD | 5.6 ± 3.2 | - | ||
Median | 5.8 | - | ||
Current age (years) | ||||
Medium ± DP | 11.3 ± 4.2 | 12.5 ± 3.5 | ||
Median | 12.3 | 13 | ||
Onset type JIA | ||||
Oligoarticular | 22 (43.1%) | - | ||
Polyarticular | 17 (33.3%) | - | ||
Systemic | 12 (23.6%) | - | ||
Course type | ||||
Oligoarticular | 29 (56.9%) | - | ||
Polyarticular | 22 (43.1%) | - | ||
Active disease treatment | 27 (52.9%) | |||
Methotrexate | 32 (62.7%) | |||
NSAIDs | 26 (51%) | |||
Chloroquine | 10 (13.9%) | |||
Folic acid | 32 (62.7%) | |||
Systemic steroids | 4 (7.8%) |